Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Dimitroulis

Showing results (201-210 of 202) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 202 results.
Anticancer Research|December 27, 2017
Histone Deacetylase Inhibitors as a Novel Targeted Therapy Against Non-small Cell Lung Cancer: Where Are We Now and What Should We Expect?Christos Damaskos, Ioannis Tomos, Nikolaos Garmpis, et al.
In Vivo (Athens, Greece)|January 6, 2021
The Impact of Peripheral Eosinophil Counts and Eosinophil to Lymphocyte Ratio (ELR) in the Clinical Course of COVID-19 Patients: A Retrospective StudyVasiliki E Georgakopoulou, Nikolaos Garmpis, Christos Damaskos, et al.
Pageof 21

Showing results (201-210 of 202) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 202 results.
Anticancer Research|December 27, 2017
Histone Deacetylase Inhibitors as a Novel Targeted Therapy Against Non-small Cell Lung Cancer: Where Are We Now and What Should We Expect?Christos Damaskos, Ioannis Tomos, Nikolaos Garmpis, et al.
In Vivo (Athens, Greece)|January 6, 2021
The Impact of Peripheral Eosinophil Counts and Eosinophil to Lymphocyte Ratio (ELR) in the Clinical Course of COVID-19 Patients: A Retrospective StudyVasiliki E Georgakopoulou, Nikolaos Garmpis, Christos Damaskos, et al.
Pageof 21